Abstract The actual Coronavirus Disease (COVID 19) pandemic is due to Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the coronavirus family …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …

In patients with severe or critical Coronavirus disease 2019 (COVID-19) manifestations, a
thromboinflammatory syndrome, with diffuse microvascular thrombosis, is increasingly …

Abstract Coronavirus disease 2019 (COVID-19) has emerged as a pandemic at the end of
2019 and continues to exert an unfavorable worldwide health impact on a large proportion …

Abstract Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases,
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …

Rising incidence of thromboembolism secondary to COVID-19 has become a global
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …

A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …

The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Abstract Corona virus 2 (SARS-CoV2/Severe Acute Respiratory Syndrome Corona Virus 2)
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …

Latest evidences from literature suggest that SARS-CoV-2 disease 2019 (COVID-19) is
commonly complicated with coagulopathy and that disseminated intravascular coagulation …